13Feb
Ahead of the pack: US M&A 2019: Biotech boosts US healthcare M&A in 2019
The healthcare sector (incorporating pharma, medical and biotech) has seen M&A valued at US$256.5 billion across 645 deals in 2019. This is a decrease of 9 percent by volume, but an increase of 121 percent by value....
By:
White & Case LLP
Related
In a decision of great interest in the M&A world, the Delaware Chancery Court recently ruled that a ...
Read More >
Private equity-backed takeovers of listed companies in Western Europe have enjoyed several strong ye...
Read More >
As mandated by the Foreign Investment Risk Review Modernization Act of 2018 (FIRRMA), the Committee ...
Read More >
On October 10, 2019, California Governor Gavin Newsom signed AB 9 into law, which, effective January...
Read More >
We have written extensively on mandatory vaccination policies and employers’ obligations to accommo...
Read More >
Seyfarth Synopsis: In complex class actions, courts have looked to Rule 23 to authorize class action...
Read More >